Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 32124 | 112 | 27.9 | 32% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1987 | 5071 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ORAL PHARMACOL THER EUT | Address | 2 | 67% | 2% | 2 |
| 2 | PHARMACEUT SCI BIOPHARMACEUT MIZUHO KU | Address | 1 | 25% | 4% | 4 |
| 3 | 31 TANABE DORIMIZUHO KU | Address | 1 | 33% | 2% | 2 |
| 4 | DEV S EDOGAWA KU | Address | 1 | 50% | 1% | 1 |
| 5 | HOSP PHARM 2630 SUGITANI | Address | 1 | 50% | 1% | 1 |
| 6 | MS MS MS | Author keyword | 1 | 50% | 1% | 1 |
| 7 | NERVE SOMATIC | Author keyword | 1 | 50% | 1% | 1 |
| 8 | RWJ 51204 | Author keyword | 1 | 50% | 1% | 1 |
| 9 | TISSUES PROTEINS | Author keyword | 1 | 50% | 1% | 1 |
| 10 | PHARMACEUT SCI BIOPHARMACEUT | Address | 1 | 29% | 2% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MS MS MS | 1 | 50% | 1% | 1 | Search MS++MS+MS | Search MS++MS+MS |
| 2 | NERVE SOMATIC | 1 | 50% | 1% | 1 | Search NERVE++SOMATIC | Search NERVE++SOMATIC |
| 3 | RWJ 51204 | 1 | 50% | 1% | 1 | Search RWJ+51204 | Search RWJ+51204 |
| 4 | TISSUES PROTEINS | 1 | 50% | 1% | 1 | Search TISSUES+PROTEINS | Search TISSUES+PROTEINS |
| 5 | PHARMACOKINETICS INTERACTION | 0 | 33% | 1% | 1 | Search PHARMACOKINETICS+INTERACTION | Search PHARMACOKINETICS+INTERACTION |
| 6 | BENZOAQUINOLIZINES | 0 | 25% | 1% | 1 | Search BENZOAQUINOLIZINES | Search BENZOAQUINOLIZINES |
| 7 | IN VITRO IN VIVO METABOLISM | 0 | 25% | 1% | 1 | Search IN+VITRO++IN+VIVO+METABOLISM | Search IN+VITRO++IN+VIVO+METABOLISM |
| 8 | COLD SWIMMING STRESS | 0 | 20% | 1% | 1 | Search COLD+SWIMMING+STRESS | Search COLD+SWIMMING+STRESS |
| 9 | DRUGS INTERACTIONS | 0 | 14% | 1% | 1 | Search DRUGS+INTERACTIONS | Search DRUGS+INTERACTIONS |
| 10 | LIPID DIET | 0 | 13% | 1% | 1 | Search LIPID+DIET | Search LIPID+DIET |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PLASMA LIPOLYTIC ACTIVITY | 1 | 50% | 1% | 1 |
| 2 | EXPERIMENTAL TRAUMA | 0 | 33% | 1% | 1 |
| 3 | BONE TISSUES | 0 | 14% | 1% | 1 |
| 4 | DISTRIBUTION DIALYSIS | 0 | 14% | 1% | 1 |
| 5 | P DIOXINS CDDS | 0 | 14% | 1% | 1 |
| 6 | SITE II | 0 | 11% | 1% | 1 |
| 7 | BUCHERER BERGS | 0 | 10% | 1% | 1 |
| 8 | QUINOLONE ACTION | 0 | 10% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Stress can affect drug pharmacokinetics via serum/tissues protein binding and blood flow rate alterations | 2012 | 3 | 42 | 26% |
| DICHLOROMETHOTREXATE - A CRITICAL REASSESSMENT | 1985 | 5 | 7 | 29% |
| REGULATION AND INTERACTION OF CHOLESTEROL, BILE-SALT AND LIPOPROTEIN SYNTHESIS IN LIVER | 1983 | 4 | 19 | 11% |
| ANTICONVULSANTS AND THE MONOOXYGENASE SYSTEM - A REVIEW OF LITERATURE | 1991 | 0 | 44 | 9% |
| IATROGENIC NUTRITIONAL DEFICIENCIES | 1982 | 9 | 10 | 10% |
| BIBLIOGRAPHY OF RECENT LITERATURE IN THERAPEUTIC DRUG-MONITORING | 1981 | 0 | 161 | 9% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ORAL PHARMACOL THER EUT | 2 | 67% | 1.8% | 2 |
| 2 | PHARMACEUT SCI BIOPHARMACEUT MIZUHO KU | 1 | 25% | 3.6% | 4 |
| 3 | 31 TANABE DORIMIZUHO KU | 1 | 33% | 1.8% | 2 |
| 4 | DEV S EDOGAWA KU | 1 | 50% | 0.9% | 1 |
| 5 | HOSP PHARM 2630 SUGITANI | 1 | 50% | 0.9% | 1 |
| 6 | PHARMACEUT SCI BIOPHARMACEUT | 1 | 29% | 1.8% | 2 |
| 7 | ABT ZELLCHEM | 0 | 33% | 0.9% | 1 |
| 8 | HLTH PROTECT AGCY E MIDLANDS | 0 | 14% | 0.9% | 1 |
| 9 | ANESTHESIOL CARDIOVASC CRIT CARE | 0 | 100% | 0.9% | 1 |
| 10 | ARETAION HOSP ATHENS | 0 | 100% | 0.9% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000124326 | METHYLTRANSFERASE I//ST 600//ST 93 |
| 2 | 0.0000096437 | COMPUTERIZED PARENTERAL NUTRITION WORKSHEET//COMBINED SOLUTIONS//NOREPINEPHRINE BITARTRATE |
| 3 | 0.0000093831 | INTERSPECIES SCALING//DMPK TRANSLAT SCI//WELL STIRRED MODEL |
| 4 | 0.0000092428 | H POINT STANDARD ADDITION METHOD//HPSAM//H POINT STANDARD ADDITIONS METHOD |
| 5 | 0.0000091323 | DANSYLSARCOSINE//N B TRANSITION//FATTY ACID AVAILABILITY |
| 6 | 0.0000081222 | GOLD WIRE ELECTRODES//NUFFIELD OPHTHALMOL NDCN//ZINC MONOCYSTEINE |
| 7 | 0.0000080337 | ELECTROPHYSIOLOGICAL DIFFERENTIATION//AUTONOMOUS BIOTECHNOL//PARAMETERS OF ZINC STATUS |
| 8 | 0.0000073651 | LIPID PHASE SEPARATIONS//SYNAPTOSOMAL MITOCHONDRIA//UNITE BIOMATH TOXICOL |
| 9 | 0.0000071373 | PNEUMOPAROTITIS//PNEUMOPAROTID//IODIDE MUMPS |
| 10 | 0.0000067737 | SOUR CHERRY SEED EXTRACT//SOUR CHERRY KERNEL//ANTI PSYCHOTIC DRUG |